6748.TWO ACRO Biomedical Co., Ltd.

Healthcare Biotechnology Taiwan OTC Exchange
160.00 TWD
Close of Nov 6, 2026
57.40 310.00
Market cap
TWD 11.5B
P/E
-
P/B
11.97x
ROE
-7.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6748.TWO undervalued?

Graham number

The Graham number of ACRO Biomedical Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ACRO Biomedical Co., Ltd. fundamental analysis

No fundamental analysis for ACRO Biomedical Co., Ltd. yet.

ACRO Biomedical Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ACRO Biomedical Co., Ltd.

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally. The company engages in manufacturing medical devices and cosmetics; research, design, production, and sales of biological tissue implants; and dental and orthopedic implants, collagen, and related derivative products. It also offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, a…

Full company profile